Public Citizen Calls on Presidential Candidates, Parties to Pledge Not to Use Dangerous, Manipulative Deepfakes
Petition to the FDA to Strengthen Safety Warning for Botox and Related Drugs and Remove Misleading Claims From Botox/Botox Cosmetic Labeling
Public Citizen v. Food and Drug Administration (Aricept 23 mg) November 05, 2012 This case was filed under the Food, Drug, and Cosmetic Act (FDCA) and the Administrative Procedure Act (APA) to compel…
PLIVA v. Mensing August 15, 2011 This Supreme Court case presents the question whether generic drug manufacturers can be held accountable for failure to take reasonable…
Allergan v. FDA September 01, 2010 Under our regulatory system, a manufacturer of a new drug cannot market or promote the product for any use not…
Public Citizen v. Food and Drug Administration (propoxyphene) July 07, 2009 This case was filed under the Food, Drug, and Cosmetic Act (FDCA) and the Administrative Procedure Act (APA) to compel…
Wyeth v. Levine March 04, 2009 Public Citizen was co-counsel for respondent Diana Levine, a professional musician, who went to the hospital for treatment of a…
McKenney v. Purepac Pharmaceutical Co. January 14, 2009 In this case, a generic drug manufacturer, Purepac Pharmaceutical Company, maintained that state-law claims alleging personal injuries from use of…
Public Citizen v. Food and Drug Administration (Fluoroquinolone) July 25, 2008 This case was filed under the Food, Drug, and Cosmetic Act (FDCA) and the Administrative Procedure Act (APA) to compel…
Warner-Lambert Co. v. Kent April 04, 2008 Traditional state tort law allows a manufacturer, alleged to have sold a defective product, to use compliance with federal standards…
Ackermann v. Wyeth Pharmaceuticals June 05, 2007 In 2002, the FDA reversed its longstanding position that federal regulation does not preempt damages claims against phramaceutical companies. Immediately…